Accelalox Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

Accelalox General Information

Description

Operator of a novel therapeutical company intended to develop therapies to treat musculoskeletal conditions. The company develops an oral, small-molecule therapy that significantly accelerates and enhances bone healing and spinal fusions, enabling patients to improve outcomes through accelerated healing and reduced complications.

Contact Information

Website
www.accelalox.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 325 Sharon Park Drive
  • Suite 310
  • Menlo Park, CA 94025
  • United States
+1 (650)
Primary Industry
Other Healthcare Services
Other Industries
Therapeutic Devices
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 325 Sharon Park Drive
  • Suite 310
  • Menlo Park, CA 94025
  • United States
+1 (650)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Accelalox Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 17-Mar-2023 Completed Generating Revenue
3. Grant 05-Aug-2010 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2010 $430K Completed Startup
1. Angel (individual) 30-Sep-2009 $430K $430K Completed Startup
To view Accelalox’s complete valuation and funding history, request access »

Accelalox Patents

  • 13

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • Pending

  • Expiring in next 12 mo

Accelalox Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20110105959-A1 Novel methods for bone treatment by modulating an arachidonic acid metabolic or signaling pathway Inactive 22-Feb-2008
US-20150320697-A1 Methods for bone treatment by modulating an arachidonic acid metabolic or signaling pathway Inactive 18-Aug-2005
AU-2006279325-B2 Methods for bone treatment by modulating an arachidonic acid metabolic or signaling pathway Inactive 18-Aug-2005
AU-2006279325-A1 Methods for bone treatment by modulating an arachidonic acid metabolic or signaling pathway Active 18-Aug-2005
CA-2619608-C Methods for bone treatment by modulating an arachidonic acid metabolic or signaling pathway Inactive 18-Aug-2005 A61K31/05
To view Accelalox’s complete patent history, request access »

Accelalox Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
U.S. Department of Health and Human Services Government
Springboard Enterprises Accelerator/Incubator Minority
To view Accelalox’s complete investors history, request access »

Ready to get started?

Request a free trial

Accelalox FAQs

  • When was Accelalox founded?

    Accelalox was founded in 2005.

  • Where is Accelalox headquartered?

    Accelalox is headquartered in Menlo Park, CA.

  • What industry is Accelalox in?

    Accelalox’s primary industry is Other Healthcare Services.

  • Is Accelalox a private or public company?

    Accelalox is a Private company.

  • What is Accelalox’s current revenue?

    The current revenue for Accelalox is .

  • How much funding has Accelalox raised over time?

    Accelalox has raised $430K.

  • Who are Accelalox’s investors?

    U.S. Department of Health and Human Services and Springboard Enterprises have invested in Accelalox.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »